GlassScriptPhysician profile
John W Stirton
NPI 1851598429
$165,269.66
in general payments reported to CMS, 2019-2025
17 companies · $23K in 2025
The $23K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $56K · 2021: $44K · 2022: $21K · 2023: $2,729 · 2024: $509 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,382.00 |
| Food and Beverage | $790.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $154,359.96 | 2019-2025 | Pinnacle, Corail, Attune |
| Applied Medical Resources Corporation | $9,000.00 | 2019-2022 | |
| Depuy Synthes Sales INC. | $1,050.07 | 2019-2025 | Monovisc, Actis, Attune |
| Pacira Pharmaceuticals Incorporated | $190.86 | 2022-2025 | Zilretta, Iovera, Exparel |
| Pacira Therapeutics, INC. | $116.60 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $105.26 | 2019-2024 | Rosa, Gel-One Cross-Linked Hyaluronate |
| Exactech, INC. | $100.49 | 2020 | |
| Osteoremedies, LLC | $91.34 | 2020 | |
| Bioventus LLC | $38.91 | 2019-2024 | Durolane |
| Vertex Pharmaceuticals Incorporated | $37.69 | 2024-2025 | |
| Axogen | $32.76 | 2025 | |
| Skeletal Dynamics INC | $31.88 | 2024 | Align, Implate, Geminus |
| Heron Therapeutics, INC. | $29.56 | 2022 | |
| Ferring Pharmaceuticals INC. | $26.70 | 2022-2024 | Euflexxa |
| Davol INC. | $25.74 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.88 | 2023 | Intellis Adaptivestim |
| Amgen INC. | $13.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stirton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.